Impact Factor
3.27
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.53
466 total citations
h5-index
25
h5 depth signal
Cited share
69.6%
144 of 207
Total citations
466
Citation footprint
Metric signal
2.64
External metric anchor
Self-citation
3.0%
14 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
536
United States
52
Iran
40
China
15
United Kingdom
14
Citing Fields of Research
Psychiatry
321
Neurosciences
145
Substance Abuse
101
Neurodevelopmental Disorders
53
Neurodegenerative Disorders
52
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
702
Articles tracked across the journal lifetime
Indexed publication set
207
144 cited publications
Last 12 months
114
9.5 publications/month
Open access share
100.0%
114 OA publications in the last year
Leading citing country
Japan
536 citing publications
Leading citing field
Psychiatry
321 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v38n1, Mar. 2018-
v38n1, Mar. 2018-
Active Coverage
Research Focus & Classification
Indexed Subjects
Psychiatry
Substance Abuse
Neurosciences
Neurodevelopmental Disorders
Anesthetic & Pain Medicine
Issuing & Sponsoring Bodies
issuing body
Nihon Shinkei Seishin Yakuri Gakkai
Broad Categories
Neurology
Psychopharmacology
Psychiatry
Substance Abuse
Neurosciences
Neurodevelopmental Disorders
Neurodegenerative Disorders
MeSH Descriptors
Neuropharmacology
Psychopharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/npr2.70176
Open DOI
Occupancy‐Guided Continuous Antipsychotic Dosing Provides a Translational Model for Evaluating Extrapyramidal Motor Liability in Mice
The therapeutic effects of antipsychotic drugs are primarily achieved through dopamine D2 receptor antagonism. However, excessive striatal D2 receptor blockade is associated with extrapyramidal side effects (EPS) in schizophrenic patient...
02
DOI 10.1002/npr2.70173
Open DOI
Perceived Utility of Combining Atypical Long‐Acting Injectable Antipsychotics With Psychosocial Interventions: An Exploratory Survey of Mid‐Career Psychiatrists in Japan
Aims: Although combining long‐acting injectable antipsychotics (LAIs) with psychosocial treatments for schizophrenia is important, psychiatrists' attitudes toward this approach remain underexplored. We investigated Japanese psychiatrists...
03
DOI 10.1002/npr2.70174
Open DOI
Neurosyphilis Concurrently Presenting With Limbic Encephalitis and Normal Pressure Hydrocephalus: A Case Report
Background: Neurosyphilis may present with a variety of clinical symptoms and neuroimaging findings and is thus likely to be overlooked. We report a case of neurosyphilis presenting with dementia, limbic encephalitis, and normal pressure...
04
DOI 10.1002/npr2.70135
Open DOI
Issue Information
05
DOI 10.1002/npr2.70171
Open DOI
Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late‐Life Depression, and Healthy Aging: A Preliminary Cross‐Sectional Study
Objective: The p75 neurotrophin receptor ectodomain (p75NTR‐ECD) has been implicated in amyloid‐β‐related neurotoxicity, but cerebrospinal fluid (CSF) levels in late‐life depression (LLD) remain uncertain. We compared clinically diagnose...
06
DOI 10.1002/npr2.70170
Open DOI
Association of Affective Temperaments With One‐Year Depressive Outcomes in Middle‐Aged and Older Patients With Mood Disorders Without Psychiatric Comorbidities
Aim: The course of depressive symptoms in mood disorders may be influenced by multiple clinical factors, making predictors of subsequent symptoms difficult to identify. This study examined whether affective temperaments are associated wi...
07
Background: Dravet syndrome (DS) is a severe and treatment‐resistant epileptic encephalopathy, most commonly caused by de novo mutations in the sodium voltage‐gated channel alpha subunit 1 ( SCN1A ) gene. Patients with DS often present w...
08
DOI 10.1002/npr2.70163
Open DOI
Prevalence of Treatment‐Resistant Schizophrenia: A Nationwide Multicenter Study
Background: Schizophrenia is characterized by positive symptoms, negative symptoms, and cognitive impairment and is primarily treated with antipsychotic medications. However, a subset of patients responds inadequately to treatment and is...
09
DOI 10.1002/npr2.70166
Open DOI
Alcohol Consumption Index as a Novel Risk Marker for Hypertension
Objectives: Habitual alcohol consumption is a risk factor for hypertension. The alcohol consumption index (ACI), which is defined as the product of mean corpuscular volume, gamma‐glutamyl transferase, and high‐density lipoprotein cholest...
10
Bibliographical & Catalog Notes
"The official journal of the Japanese Society of Neuropsychopharmacology."